1. Dirks, J., Remuzzi, G., Horton, S., Schieppati, A. & Rizvi, S. A. H. in Disease Control Priorities in Developing Countries (eds Jamison, D. T. et al.) 695–706 (Oxford University Press and The World Bank, New York, 2006).
2. Gridelli, B. & Remuzzi, G. Strategies for making more organs available for transplantation. N. Engl. J. Med. 343, 404–410 (2000).
3. Collins, A. J. The hemoglobin link to adverse outcomes. Adv. Stud Med. 3, S14–S17 (2003).
4. Hostetter, T. H., Olson, J. L., Rennke, H. G., Venkatachalam, M. A. & Brenner, B. M. Hyperfiltration in remnant nephrons: a potentially adverse response to renal ablation. Am. J. Physiol. 241, F85–F93 (1981).
5. Remuzzi, G., Ruggenenti, P. & Perico, N. Chronic renal diseases: renoprotective benefits of renin–angiotensin system inhibition. Ann. Intern. Med. 136, 604–615 (2002).